SCHEMBL17505227

SCHEMBL17505227

O=C(O)c1cc2ncc(F)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.47
▸ HPGD P15428 3/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ NFKB1 P19838 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ PDPK1 O15530 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ APEX1 P27695 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ DAO P14920 5/20 0.44
▸ IDO1 P14902 1/20 0.40
▸ TDO2 P48775 1/20 0.40
▸ EIF4A3 P38919 2/20 0.40
▸ GPR35 Q9HC97 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ SRD5A2 P31213 1/20 0.40
▸ ALOX15 P16050 1/20 0.38
▸ BLM P54132 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4067573 0.81 GRIN1 (0.53) KDM4EHPGDHSD17B10CYP2C19LMNA
SCHEMBL24690029 0.79 DAO (0.44) KDM4EHPGDHSD17B10NFKB1ALDH1A1
SCHEMBL17505244 0.79 DYRK1A (0.44) KDM4EHPGDHSD17B10NFKB1ALDH1A1
SCHEMBL17505325 0.79 PIN1 (0.47) KDM4EHPGDHSD17B10NFKB1TDP1
SCHEMBL27352224 0.76 IDO1 (0.44) KDM4EHPGDHSD17B10ALDH1A1CYP2C19
SCHEMBL5474613 0.74 DAO (0.45) KDM4EHPGDHSD17B10NFKB1ALDH1A1
SCHEMBL3359598 0.72 DAO (0.54) KDM4EDAO
SCHEMBL297192 0.72 KDM4E (0.51) KDM4EHPGDHSD17B10NFKB1ALDH1A1
SCHEMBL29414319 0.70 HRH4 (0.57) KDM4EHPGDHSD17B10ALDH1A1CYP2C19
SCHEMBL1203267 0.70 HRH4 (0.57) KDM4EHPGDHSD17B10ALDH1A1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022131-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2026-01-22 — — US disclosed
US-12473302-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2025-11-18 — — US disclosed
US-20240287092-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2024-08-29 — — US disclosed
US-11919913-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2024-03-05 — — US disclosed
US-20210363155-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-11-25 — — US disclosed
US-11028098-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-06-08 — — US disclosed
EP-3495357-B1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE UNIV COLUMBIA (US) 2021-05-05 — — EP disclosed
EP-3495357-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE The Trustees of Columbia University in the City of New York (US) 2019-06-12 — — EP disclosed
US-10273243-B2 4-phenylpiperidines, their preparation and use THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-04-30 — — US disclosed
US-20190031681-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2019-01-31 — — US disclosed
EP-2968304-B1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE UNIV COLUMBIA (US) 2018-10-10 — — EP disclosed
US-20160046648-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-02-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10273243-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, CYP4F3 KDM4E 1332/4885HPGD 3012/4885HSD17B10 3280/4885
US-20240287092-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE HTR3C, HRH4, DRD3 KDM4E 1319/4885HPGD 2848/4885HSD17B10 3363/4885
US-12473302-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, DRD3 KDM4E 1319/4885HPGD 2848/4885HSD17B10 3363/4885
US-11919913-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, CYP4F3 KDM4E 1279/4885HPGD 2810/4885HSD17B10 3289/4885
US-20210363155-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE HTR3C, HRH4, CYP4F3 KDM4E 1279/4885HPGD 2810/4885HSD17B10 3289/4885
US-20160046648-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE HTR3C, HRH4, CYP4F3 KDM4E 1332/4885HPGD 3012/4885HSD17B10 3280/4885
US-11028098-B2 4-phenylpiperidines, their preparation and use HTR3C, HRH4, CYP4F3 KDM4E 1343/4885HPGD 2925/4885HSD17B10 3299/4885
US-20190031681-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE HTR3C, HRH4, CYP4F3 KDM4E 1343/4885HPGD 2925/4885HSD17B10 3299/4885
US-20260022131-A1 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE CLN6, NR2E3, CBR3 KDM4E 3025/4885HPGD 2855/4885HSD17B10 2530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback